MAPT and Alzheimer disease: Furthermore, the Ser262 phospho-epitope has been identified as one of the earliest post-transcriptional modifications in AD [50], therefore, specific increases in Ser262 phosphorylation in the absence of more general hyperphosphorylation suggests that this could be an early change associated with synaptic hyperactivity at the onset of tau pathology.